ConductScience.org, home

Paper35995339

Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.

Bonsignore M and 8 others. J Hosp Infect, 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants. Papers, record 35995339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35995339

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.
PubMed
Journal
J Hosp Infect
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2022-10-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonsignore MM
2Hohenstein SS
3Kodde CC
4Leiner JJ
5Schwegmann KK
6Bollmann AA
7Möller RR
8Kuhlen RR
9Nachtigall II

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Cross InfectionMajor topic
Humans
SARS-CoV-2
Pandemics
Germany
Hospitals

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42528337Mathematical Modeling of Viral RNA Copies in Indoor Environments: Pre-Processor for Risk Assessment and Decision-Making Support Tool for Public Health.Risk Anal2026https://conductscience.org/library/papers/42528337PubMed
41899213Lessons from Two Early COVID-19 Hospital Outbreaks in Germany to Inform Strategies for Controlling Emerging Nosocomial Outbreaks of Highly Transmissible Respiratory Viruses.J Clin Med2026https://conductscience.org/library/papers/41899213PubMed
39919135Health-economic evaluation of the outpatient, inpatient, and public health sector in Germany: Insights from the first three COVID-19 waves.PLoS One2025https://conductscience.org/library/papers/39919135PubMed
39449698Hospital-borne hazardous air pollutants and air cleaning strategies amid the surge of SARS-CoV-2 new variants.Heliyon2024https://conductscience.org/library/papers/39449698PubMed
39335015
Incidence and Predictors of Healthcare-Associated Infections in Patients Admitted to a Temporary Intensive Care Unit during the COVID-19 Pandemic Waves: A Two-Year (2021-2023) Retrospective Cohort Study in Rome, Italy.
Antibiotics (Basel)2024https://conductscience.org/library/papers/39335015PubMed
39187755SARS-CoV-2 infections in patients, health care workers and hospital outbreaks during the first 3 waves of the pandemic: a retrospective analysis in a secondary care hospital network in Germany.BMC Infect Dis2024https://conductscience.org/library/papers/39187755PubMed
39008853Morbidity and Mortality of Hospital-Onset SARS-CoV-2 Infections Due to Omicron Versus Prior Variants : A Propensity-Matched Analysis.Ann Intern Med2024https://conductscience.org/library/papers/39008853PubMed
38932363Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study.Vaccines (Basel)2024https://conductscience.org/library/papers/38932363PubMed
38806219Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nosocomial Respiratory Viral Infections on the Leeside of the Pandemic.Respir Care2024https://conductscience.org/library/papers/38806219PubMed
38156200Incidence and outcome of hospital-acquired COVID-19 infections in secondary and tertiary care hospitals in the era of COVID-19 vaccinations.Antimicrob Steward Healthc Epidemiol2023https://conductscience.org/library/papers/38156200PubMed
37948082Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves.JAMA Netw Open2023https://conductscience.org/library/papers/37948082PubMed
37639273Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022.JAMA Netw Open2023https://conductscience.org/library/papers/37639273PubMed
37162815Estimating time-dependent contact: a multi-strain epidemiological model of SARS-CoV-2 on the island of Ireland.Glob Epidemiol2023https://conductscience.org/library/papers/37162815PubMed
37125157Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection.Front Microbiol2023https://conductscience.org/library/papers/37125157PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35995339

GET https://conductscience.org/api/papers/v1/35995339/authors